久久久久国产精品人妻,国产爆乳乱码女大生Av,日韩国产亚洲欧美成人图片,国产无遮挡又黄又爽不要vip软件,美女胸18下看禁止免费视频

国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区

BIZCHINA> Center

Markets

Biotech drug to play major role

By Su Yue (chinadaily.com.cn)
Updated: 2006-09-22 08:52

Pharmaceutical technology has been playing an increasingly important role for large-scale medicine producers, and analysis indicates that 60 percent of their sales revenue will come from biotech medicines by 2010.

It is predicted that the annual sales volume of monoclonal antibodies (mAbs) will reach US$18 billion, tantamount to a 26.2 percent compound annual growth rate (CAGR). The CAGR figure for small molecule medicines for this period is expected to remain at the low level of 0.9 percent.

Many pharmaceutical firms have devoted efforts in developing small molecule medicines for the past few years, in the hopes of effectively improving their sales revenue. However, this concept needs to be changed since the biotech market, especially that of monoclonal medicines, is growing dramatically.

......

The full text is available in the Sept-Oct Issue ofChina Medicine.

(For more biz stories, please visit Industries)

^{<blockquote id="fyesa"></blockquote>}